A young adult with microcytic anemia: what is the first-line therapy and how do you monitor response?

Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

A young adult with microcytic anemia: what is the first-line therapy and how do you monitor response?

Iron deficiency anemia is the most common cause of microcytic anemia in young adults. The first-line treatment is oral iron supplementation to replenish iron stores and support erythropoiesis. A key early sign that the marrow is responding is a rise in reticulocytes within about 7–10 days after starting iron. This rapid shift shows iron is becoming available for red cell production. Over the next several weeks, hemoglobin should increase gradually (roughly about 1 g/dL every 2–3 weeks). After about 2–3 months, hemoglobin should approach normal levels and iron stores should be repleted, which is reflected by a rise in ferritin (iron stores) and improvement in red cell indices. Monitoring may also include assessing clinical improvement in fatigue and pallor. Other options are not first-line for uncomplicated iron deficiency. Intravenous iron is reserved for cases where oral iron isn’t tolerated or absorption is impaired. Blood transfusion is only for severe, symptomatic anemia or unstable patients. Vitamin B12 supplementation addresses a different, macrocytic anemia and is not appropriate for microcytosis due to iron deficiency.

Iron deficiency anemia is the most common cause of microcytic anemia in young adults. The first-line treatment is oral iron supplementation to replenish iron stores and support erythropoiesis. A key early sign that the marrow is responding is a rise in reticulocytes within about 7–10 days after starting iron. This rapid shift shows iron is becoming available for red cell production.

Over the next several weeks, hemoglobin should increase gradually (roughly about 1 g/dL every 2–3 weeks). After about 2–3 months, hemoglobin should approach normal levels and iron stores should be repleted, which is reflected by a rise in ferritin (iron stores) and improvement in red cell indices. Monitoring may also include assessing clinical improvement in fatigue and pallor.

Other options are not first-line for uncomplicated iron deficiency. Intravenous iron is reserved for cases where oral iron isn’t tolerated or absorption is impaired. Blood transfusion is only for severe, symptomatic anemia or unstable patients. Vitamin B12 supplementation addresses a different, macrocytic anemia and is not appropriate for microcytosis due to iron deficiency.

More practice questions